Related references
Note: Only part of the references are listed.Tetra-Substituted Pyridinylimidazoles As Dual Inhibitors of p38α Mitogen-Activated Protein Kinase and c-Jun N-Terminal Kinase 3 for Potential Treatment of Neurodegenerative Diseases
Felix Muth et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Inhibitors of c-Jun N-Terminal Kinases: An Update
Pierre Koch et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
JNK signalling in cancer: in need of new, smarter therapeutic targets
Concetta Bubici et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Novel Hinge-Binding Motifs for Janus Kinase 3 Inhibitors: A Comprehensive Structure-Activity Relationship Study on Tofacitinib Bioisosteres
Matthias Gehringer et al.
CHEMMEDCHEM (2014)
Halogen-enriched fragment libraries as chemical probes for harnessing halogen bonding in fragment-based lead discovery
Markus O. Zimmermann et al.
FUTURE MEDICINAL CHEMISTRY (2014)
Design and Synthesis of Highly Potent and Isoform Selective JNK3 Inhibitors: SAR Studies on Aminopyrazole Derivatives
Ke Zheng et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Development of amino-pyrimidine inhibitors of c-Jun N-terminal kinase (JNK): Kinase profiling guided optimization of a 1,2,3-benzotriazole lead
Wylie S. Palmer et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Development of indole/indazole-aminopyrimidines as inhibitors of c-Jun N-terminal kinase (JNK): Optimization for JNK potency and physicochemical properties
Leyi Gong et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
The DLK signalling pathway-a double-edged sword in neural development and regeneration
Andrea Tedeschi et al.
EMBO REPORTS (2013)
JNK inhibitors as anti-inflammatory and neuroprotective agents
Piotr P. Graczyk
FUTURE MEDICINAL CHEMISTRY (2013)
MAP Kinase Phosphatase 1 (MKP-1/DUSP1) Is Neuroprotective in Huntington's Disease via Additive Effects of JNK and p38 Inhibition
David M. Taylor et al.
JOURNAL OF NEUROSCIENCE (2013)
A public-private partnership to unlock the untargeted kinome
Stefan Knapp et al.
NATURE CHEMICAL BIOLOGY (2013)
Discovery of a novel series of 4-quinolone JNK inhibitors
Leyi Gong et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Aminopurine based JNK inhibitors for the prevention of ischemia reperfusion injury
Veronique Plantevin Krenitsky et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Discovery of CC-930, an orally active anti-fibrotic JNK inhibitor
Veronique Plantevin Krenitsky et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Potent Galloyl-Based Selective Modulators Targeting Multidrug Resistance Associated Protein 1 and P-glycoprotein
Raffaella Zoe Pellicani et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Reversible targeting of noncatalytic cysteines with chemically tuned electrophiles
Iana M. Serafimova et al.
NATURE CHEMICAL BIOLOGY (2012)
Identification of an Adamantyl Azaquinolone JNK Selective Inhibitor
Nancy-Ellen Haynes et al.
ACS MEDICINAL CHEMISTRY LETTERS (2012)
Development of JNK2-Selective Peptide Inhibitors That Inhibit Breast Cancer Cell Migration
Tamer S. Kaoud et al.
ACS CHEMICAL BIOLOGY (2011)
JNK-1 Deficiency Limits Macrophage-Mediated Antigen-Induced Arthritis
Monica Guma et al.
ARTHRITIS AND RHEUMATISM (2011)
Design, synthesis, and structure-activity relationship studies of thiophene-3-carboxamide derivatives as dual inhibitors of the c-Jun N-terminal kinase
Surya K. De et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2011)
Design and synthesis of a novel, orally active, brain penetrant, tri-substituted thiophene based JNK inhibitor
Simeon Bowers et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Design and synthesis of brain penetrant selective JNK inhibitors with improved pharmacokinetic properties for the prevention of neurodegeneration
Simeon Bowers et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Design and Characterization of a Potent and Selective Dual ATP- and Substrate-Competitive Subnanomolar Bidentate c-Jun N-Terminal Kinase (JNK) Inhibitor
John L. Stebbins et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
The resurgence of covalent drugs
Juswinder Singh et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Protein kinases: evolution of dynamic regulatory proteins
Susan S. Taylor et al.
TRENDS IN BIOCHEMICAL SCIENCES (2011)
c-Jun N-terminal kinase (JNK) signaling: Recent advances and challenges
Marie A. Bogoyevitch et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2010)
X-ray crystal structure of JNK2 complexed with the p38α inhibitor BIRB796: Insights into the rational design of DFG-out binding MAP kinase inhibitors
Andreas Kuglstatter et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Design and synthesis of disubstituted thiophene and thiazole based inhibitors of JNK
Roy K. Hom et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Synthesis, Biological Evaluation, X-ray Structure, and Pharmacokinetics of Aminopyrimidine c-jun-N-terminal Kinase (JNK) Inhibitors
Ted Kamenecka et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Small Molecule JNK (c-Jun N-Terminal Kinase) Inhibitors
M. Arshad Siddiqui et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
The Role of JNK Proteins in Metabolism
Sara N. Vallerie et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Therapeutic Protein Kinase Inhibitors
S. K. Grant
CELLULAR AND MOLECULAR LIFE SCIENCES (2009)
Implication of the JNK pathway in a rat model of Huntington's disease
V. Perrin et al.
EXPERIMENTAL NEUROLOGY (2009)
Signal integration by JNK and p38 MAPK pathways in cancer development
Erwin F. Wagner et al.
NATURE REVIEWS CANCER (2009)
Small-molecule inhibitors binding to protein kinase. Part II: the novel pharmacophore approach of type II and type III inhibition
A. C. Backes et al.
EXPERT OPINION ON DRUG DISCOVERY (2008)
JNK pathway: diseases and therapeutic potential
Jie Cui et al.
ACTA PHARMACOLOGICA SINICA (2007)
Uses for JNK: the many and varied substrates of the c-Jun N-terminal kinases
Marie A. Bogoyevitch et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2006)
Design and synthesis of the first generation of novel potent, selective, and in vivo active (benzothiazol-2-yl)acetonitrile inhibitors of the c-Jun N-terminal kinase
P Gaillard et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
A small molecule-kinase interaction map for clinical kinase inhibitors
MA Fabian et al.
NATURE BIOTECHNOLOGY (2005)
Structural basis for the selective inhibition of JNK1 by the scaffolding protein JIP1 and SP600125
JS Heo et al.
EMBO JOURNAL (2004)
Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases
GL Johnson et al.
SCIENCE (2002)
The protein kinase complement of the human genome
G Manning et al.
SCIENCE (2002)
SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase
BL Bennett et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Cell-permeable peptide inhibitors of JNK novel blockers of beta-cell death
C Bonny et al.
DIABETES (2001)
Share Paper
